CDC has collaborated with public health institutions in Central America since the 1960s. Through these alliances, CDC has been able to address the region’s priority challenges from malaria to flu. These alliances have increased from a single field station in El Salvador to a regional office in Guatemala. CDC’s current programs include HIV/AIDS, the Field Epidemiology Training Program (FETP), and the Influenza Preparedness, Detection, and Response program.
Download Overview Fact Sheet
Staff
CDC office (physical presence)
No U.S. Assignees
1 Locally Employed
El Salvador at a Glance
Population: 6,227,500
Per capita income: $6,420
Life expectancy at birth women/men: 77/67 yrs
Infant mortality rate: 20/1000 live births
Source: Population Reference Bureau World Population Data Sheet, 2011
Top 10 Causes of Death
Source: El Salvador MOH, 2011
- Ischaemic heart disease
- Stroke
- Liver diseases
- Other heart diseases
- Head trauma
- Diabetes
- Pneumonia
- Genitourinary system diseases
- Perinatal diseases
- Gastrointestinal diseases
What CDC Is Doing
- Page last reviewed: December 6, 2013
- Page last updated: December 6, 2013
- Content source:
Global Health
Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.
ShareCompartir

One model program in progress is the HIV and sexually transmitted infections (STI) surveillance and control program focusing on the most-at-risk populations (better known by the Spanish derived acronym, VICITS). VICITS is a comprehensive HIV and STI prevention program linked to surveillance data analysis in Central America. It is an HIV prevention strategy that combines STI diagnosis and treatment among the most-at-risk populations, promotes condom use, implements behavioral changes, and uses an information system to monitor the impact of the project. The intervention program in El Salvador includes strengthening STI management by training healthcare personnel, strengthening counseling for risk reduction, and promoting condom use. The intervention will also improve laboratory STI and HIV diagnostic capacity by training healthcare personnel and by providing equipment and reagents.
